HB 987: Relating to the regulation of abortion, including abortion complication reporting and the repeal of certain laws prohibiting abortion.
- Session
- 90th Texas Legislature, Regular Session
- Status
- Filed
- Filed
- Nov 9, 2026
- Most recent action
- 11/09/2026 H Filed
- Authors
- Bowers
- Official subjects
- Abortion; MEDICINE & PRESCRIPTION DRUGS; PACKAGING & LABELING REQUIREMENTS
AI summary (not official): Repeals specified abortion prohibitions and revises rules for abortion medication and complication reporting
Topics: Healthcare, Criminal justice. From AI review or caption rules.
Laws this bill changes
- repeals Health and Safety Code chapter 170A
- amends Health and Safety Code § 171.006
- amends Health and Safety Code § 171.061
- amends Health and Safety Code § 171.063
- repeals Health and Safety Code § 171.065
- repeals Health and Safety Code § 171.066
- amends Health and Safety Code § 171.206
- amends Health and Safety Code § 171.207
- repeals Health and Safety Code § 171.0631
- repeals Health and Safety Code § 171.0632
Bill text (Introduced)
By: Bowers H.B. No. 987
A BILL TO BE ENTITLED
AN ACT
relating to the regulation of abortion, including abortion complication reporting and the repeal of certain laws prohibiting abortion.
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
SECTION 1.
Sections 171.006(a) and (b), Health and Safety Code, as added by Chapter 4 (H.B. 13), Acts of the 85th Legislature, 1st Called Session, 2017, are amended to read as follows:
(a) In this section, "abortion complication" means any harmful event or adverse outcome with respect to a patient related to an abortion that is performed on the patient and that is diagnosed or treated by a health care practitioner or at a health care facility and includes:
(1) shock;
(2) uterine perforation;
(3) cervical laceration;
(4) hemorrhage;
(5) aspiration or allergic response;
(6) infection;
(7) sepsis;
(8) death of the patient;
(9) incomplete abortion;
(10) damage to the uterus; or
(11) an infant born alive after the abortion
(b) The reporting requirements of this section apply only to:
(1) a physician who:
(A) performs at an abortion facility an abortion that results in an abortion complication diagnosed or treated by that physician; or
(B) diagnoses or treats at an abortion facility an abortion complication that is the result of an abortion performed by another physician at the facility; or
(2) a health care facility that is a hospital, abortion facility, freestanding emergency medical care facility, or health care facility that provides emergency medical care, as defined by Section 773.003.
SECTION 2.
Section 171.061, Health and Safety Code, is amended by adding Subdivision (3) and amending Subdivision (8-a) to read as follows:
(3) "Final printed label" means the informational document approved by the United States Food and Drug Administration for an abortion-inducing drug that:
(A) outlines the protocol authorized by that agency and agreed to by the drug company applying for authorization of the drug by that agency; and
(B) delineates the manner in which a drug is to be used according to approval by that agency.
(8-a) "Provide" means, as used with regard to abortion-inducing drugs, any act of giving, selling, dispensing, administering, or otherwise providing or prescribing an abortion-inducing drug.
SECTION 3.
Section 171.063, Health and Safety Code, is amended by amending Subsections (a), (c), and (e) and adding Subsection (b) to read as follows:
(a) A person may not knowingly provide an abortion-inducing drug to a pregnant woman for the purpose of inducing an abortion in the pregnant woman or enabling another person to induce an abortion in the pregnant woman unless:
(1) the person who provides the abortion-inducing drug is a physician; and
(2) except as otherwise provided by Subsection (b), the provision of the abortion-inducing drug satisfies the protocol tested and authorized by the United States Food and Drug Administration as outlined in the final printed label of the abortion-inducing drug.
(b) A person may provide the abortion-inducing drug in the dosage amount prescribed by the clinical management guidelines defined by the American College of Obstetricians and Gynecologists Practice Bulletin as those guidelines existed on January 1, 2013.
The text continues: full text of HB 987.
Links
- Full bill text (Introduced), Markdown copy of the official file
- Record, history and review for AI agents
- Official bill history on Texas Legislature Online
Texas Bill Atlas is an independent research tool, not an official state website.